Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,813 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹55,194.1 Cr -1.6% -5.3% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹106,825.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr 2.2% -1.6% 0% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.6%

-5.3%

31.8%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses